nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—SLC22A8—optic choroid—age related macular degeneration	0.0342	0.161	CbGeAlD
Valproic Acid—OGDH—eye—age related macular degeneration	0.0227	0.107	CbGeAlD
Valproic Acid—OGDH—retina—age related macular degeneration	0.0225	0.106	CbGeAlD
Valproic Acid—OGDH—connective tissue—age related macular degeneration	0.0219	0.103	CbGeAlD
Valproic Acid—HDAC9—eye—age related macular degeneration	0.02	0.0942	CbGeAlD
Valproic Acid—ABAT—eye—age related macular degeneration	0.0136	0.0639	CbGeAlD
Valproic Acid—ABAT—retina—age related macular degeneration	0.0135	0.0633	CbGeAlD
Valproic Acid—HDAC2—eye—age related macular degeneration	0.0102	0.0481	CbGeAlD
Valproic Acid—HDAC2—retina—age related macular degeneration	0.0101	0.0477	CbGeAlD
Valproic Acid—HDAC2—connective tissue—age related macular degeneration	0.00987	0.0464	CbGeAlD
Valproic Acid—SLC16A1—eye—age related macular degeneration	0.0091	0.0428	CbGeAlD
Valproic Acid—SLC16A1—retina—age related macular degeneration	0.00902	0.0424	CbGeAlD
Valproic Acid—SLC22A8—eye—age related macular degeneration	0.00688	0.0323	CbGeAlD
Valproic Acid—SLC22A5—retina—age related macular degeneration	0.00515	0.0242	CbGeAlD
Valproic Acid—PTGS1—connective tissue—age related macular degeneration	0.00393	0.0185	CbGeAlD
Valproic Acid—HDAC9—Disease—RPE65—age related macular degeneration	0.00308	0.00391	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—SERPING1—age related macular degeneration	0.00302	0.00383	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—F13B—age related macular degeneration	0.00293	0.00373	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—NMNAT1—age related macular degeneration	0.00279	0.00354	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—SERPING1—age related macular degeneration	0.00276	0.0035	CbGpPWpGaD
Valproic Acid—UGT1A3—NRF2 pathway—SQSTM1—age related macular degeneration	0.00271	0.00345	CbGpPWpGaD
Valproic Acid—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—age related macular degeneration	0.0027	0.00344	CbGpPWpGaD
Valproic Acid—SLC22A6—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00269	0.00341	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—RAD51B—age related macular degeneration	0.00261	0.00332	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—CST3—age related macular degeneration	0.00253	0.00321	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—ABCA4—age related macular degeneration	0.00248	0.00315	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—RDH8—age related macular degeneration	0.00247	0.00313	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—ELOVL4—age related macular degeneration	0.00244	0.00309	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—NMNAT1—age related macular degeneration	0.00244	0.00309	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—SLC16A8—age related macular degeneration	0.00243	0.00309	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—RAD51B—age related macular degeneration	0.00239	0.00304	CbGpPWpGaD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00236	0.003	CbGpPWpGaD
Valproic Acid—UGT2B7—NRF2 pathway—SQSTM1—age related macular degeneration	0.00231	0.00293	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—SLC16A8—age related macular degeneration	0.00222	0.00282	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00218	0.00277	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—RHO—age related macular degeneration	0.00216	0.00274	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—RPE65—age related macular degeneration	0.00216	0.00274	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—ELOVL4—age related macular degeneration	0.00213	0.0027	CbGpPWpGaD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.0021	0.00267	CbGpPWpGaD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.0021	0.00267	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—NMNAT1—age related macular degeneration	0.00203	0.00258	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00203	0.00258	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—SLC16A8—age related macular degeneration	0.00196	0.00249	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00195	0.00247	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00195	0.00247	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—LIPC—age related macular degeneration	0.00191	0.00243	CbGpPWpGaD
Valproic Acid—CYP2C19—Melatonin metabolism and effects—APOE—age related macular degeneration	0.0019	0.00241	CbGpPWpGaD
Valproic Acid—UGT1A9—NRF2 pathway—SQSTM1—age related macular degeneration	0.00187	0.00238	CbGpPWpGaD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00186	0.00236	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—CETP—age related macular degeneration	0.00185	0.00234	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00184	0.00233	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00181	0.0023	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00181	0.0023	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—ELOVL4—age related macular degeneration	0.00178	0.00226	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00177	0.00225	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—ABCA4—age related macular degeneration	0.00174	0.00221	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—SLC16A8—age related macular degeneration	0.00172	0.00218	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00164	0.00208	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00164	0.00208	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—LIPC—age related macular degeneration	0.00163	0.00207	CbGpPWpGaD
Valproic Acid—UGT1A9—PPARA activates gene expression—CD36—age related macular degeneration	0.00158	0.002	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—NMNAT1—age related macular degeneration	0.00157	0.00199	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—CETP—age related macular degeneration	0.00157	0.00199	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—SQSTM1—age related macular degeneration	0.00155	0.00197	CbGpPWpGaD
Valproic Acid—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—age related macular degeneration	0.00154	0.00196	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00153	0.00195	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—RDH8—age related macular degeneration	0.00153	0.00194	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—NMNAT1—age related macular degeneration	0.00153	0.00194	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—RHO—age related macular degeneration	0.00151	0.00192	CbGpPWpGaD
Valproic Acid—CYP1A2—Melatonin metabolism and effects—APOE—age related macular degeneration	0.00148	0.00188	CbGpPWpGaD
Valproic Acid—CYP2A6—NRF2 pathway—SQSTM1—age related macular degeneration	0.00144	0.00184	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00144	0.00183	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—SLC16A8—age related macular degeneration	0.00143	0.00182	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—NMNAT1—age related macular degeneration	0.0014	0.00178	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00138	0.00176	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—ELOVL4—age related macular degeneration	0.00137	0.00174	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00137	0.00173	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00137	0.00173	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—CST3—age related macular degeneration	0.00135	0.00171	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—RPE65—age related macular degeneration	0.00134	0.0017	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—NMNAT1—age related macular degeneration	0.0013	0.00166	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—ERCC6—age related macular degeneration	0.00125	0.00158	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—ELOVL4—age related macular degeneration	0.00122	0.00155	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—TGFBR1—age related macular degeneration	0.00121	0.00154	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.00116	0.00147	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—ELOVL4—age related macular degeneration	0.00114	0.00145	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—NMNAT1—age related macular degeneration	0.00114	0.00145	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00114	0.00145	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—NMNAT1—age related macular degeneration	0.00111	0.00141	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—CD36—age related macular degeneration	0.00111	0.00141	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—SLC16A8—age related macular degeneration	0.00111	0.0014	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—ABCA4—age related macular degeneration	0.00108	0.00137	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—RDH8—age related macular degeneration	0.00107	0.00136	CbGpPWpGaD
Valproic Acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—age related macular degeneration	0.00106	0.00135	CbGpPWpGaD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00104	0.00132	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—LIPC—age related macular degeneration	0.001	0.00128	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—ELOVL4—age related macular degeneration	0.000997	0.00127	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—SLC16A8—age related macular degeneration	0.000985	0.00125	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—APOE—age related macular degeneration	0.000978	0.00124	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—CETP—age related macular degeneration	0.000969	0.00123	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—ELOVL4—age related macular degeneration	0.000969	0.00123	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000962	0.00122	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—CD36—age related macular degeneration	0.000943	0.0012	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—RHO—age related macular degeneration	0.000936	0.00119	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—RPE65—age related macular degeneration	0.000935	0.00119	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.000931	0.00118	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—SLC16A8—age related macular degeneration	0.000919	0.00117	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—NMNAT1—age related macular degeneration	0.000901	0.00114	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000894	0.00114	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—LIPC—age related macular degeneration	0.000878	0.00112	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TGFBR1—age related macular degeneration	0.000849	0.00108	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—CETP—age related macular degeneration	0.000847	0.00108	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—APOE—age related macular degeneration	0.000832	0.00106	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.000831	0.00106	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000808	0.00103	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—SLC16A8—age related macular degeneration	0.000803	0.00102	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ELOVL4—age related macular degeneration	0.000788	0.001	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—SLC16A8—age related macular degeneration	0.000781	0.000993	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—SQSTM1—age related macular degeneration	0.00077	0.000977	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.000758	0.000963	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ABCA4—age related macular degeneration	0.000754	0.000957	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—NMNAT1—age related macular degeneration	0.000735	0.000933	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—LIPC—age related macular degeneration	0.000733	0.000931	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00073	0.000927	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—CD36—age related macular degeneration	0.000721	0.000916	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—CETP—age related macular degeneration	0.000707	0.000898	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000704	0.000894	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—NMNAT1—age related macular degeneration	0.000695	0.000882	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000674	0.000857	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—CD36—age related macular degeneration	0.00066	0.000838	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—RHO—age related macular degeneration	0.000656	0.000833	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—APOE—age related macular degeneration	0.00065	0.000826	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.000648	0.000823	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ELOVL4—age related macular degeneration	0.000642	0.000816	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—SLC16A8—age related macular degeneration	0.000635	0.000807	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ELOVL4—age related macular degeneration	0.000607	0.000771	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000595	0.000756	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CST3—age related macular degeneration	0.000585	0.000744	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—CD36—age related macular degeneration	0.000583	0.00074	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000574	0.000729	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—LIPC—age related macular degeneration	0.000566	0.000719	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—NMNAT1—age related macular degeneration	0.000561	0.000712	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.000552	0.000701	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—NMNAT1—age related macular degeneration	0.000548	0.000696	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—CETP—age related macular degeneration	0.000546	0.000694	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—TGFBR1—age related macular degeneration	0.000526	0.000668	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—SLC16A8—age related macular degeneration	0.000518	0.000658	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—APOE—age related macular degeneration	0.000514	0.000653	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—CD36—age related macular degeneration	0.000509	0.000647	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—LIPC—age related macular degeneration	0.000504	0.000641	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ELOVL4—age related macular degeneration	0.00049	0.000622	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—SLC16A8—age related macular degeneration	0.00049	0.000622	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—C3—age related macular degeneration	0.000489	0.000621	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—CETP—age related macular degeneration	0.000487	0.000618	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ELOVL4—age related macular degeneration	0.000479	0.000608	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—NMNAT1—age related macular degeneration	0.000475	0.000603	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—LIPC—age related macular degeneration	0.00047	0.000598	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—APOE—age related macular degeneration	0.000455	0.000578	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—CETP—age related macular degeneration	0.000454	0.000577	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—APOE—age related macular degeneration	0.000449	0.000571	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—KDR—age related macular degeneration	0.000446	0.000566	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—CD36—age related macular degeneration	0.000425	0.00054	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—NMNAT1—age related macular degeneration	0.000424	0.000538	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000423	0.000538	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ELOVL4—age related macular degeneration	0.000415	0.000527	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—LIPC—age related macular degeneration	0.000411	0.000522	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—LIPC—age related macular degeneration	0.0004	0.000508	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—CETP—age related macular degeneration	0.000397	0.000504	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—SLC16A8—age related macular degeneration	0.000395	0.000502	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—NMNAT1—age related macular degeneration	0.000386	0.000491	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—SLC16A8—age related macular degeneration	0.000386	0.00049	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—CETP—age related macular degeneration	0.000386	0.00049	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000384	0.000488	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CCL2—age related macular degeneration	0.000383	0.000486	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—APOE—age related macular degeneration	0.000375	0.000476	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000373	0.000474	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000371	0.000471	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ELOVL4—age related macular degeneration	0.00037	0.00047	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000368	0.000467	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000345	0.000438	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—VEGFA—age related macular degeneration	0.000344	0.000436	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000343	0.000436	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ELOVL4—age related macular degeneration	0.000338	0.000429	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—SLC16A8—age related macular degeneration	0.000334	0.000425	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000334	0.000424	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000331	0.00042	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—NMNAT1—age related macular degeneration	0.00033	0.000419	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—CD36—age related macular degeneration	0.000328	0.000417	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—LIPC—age related macular degeneration	0.000325	0.000413	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—VEGFA—age related macular degeneration	0.000314	0.000399	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CETP—age related macular degeneration	0.000314	0.000398	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000313	0.000397	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000304	0.000387	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000302	0.000383	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—SLC16A8—age related macular degeneration	0.000298	0.000379	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—CD36—age related macular degeneration	0.000293	0.000372	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—APOE—age related macular degeneration	0.00029	0.000368	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ELOVL4—age related macular degeneration	0.000289	0.000366	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—APOE—age related macular degeneration	0.000282	0.000358	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—CD36—age related macular degeneration	0.000273	0.000347	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SLC16A8—age related macular degeneration	0.000272	0.000346	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000267	0.00034	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—LIPC—age related macular degeneration	0.000265	0.000337	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—APOE—age related macular degeneration	0.000258	0.000328	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000258	0.000328	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CETP—age related macular degeneration	0.000256	0.000325	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000255	0.000324	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—LIPC—age related macular degeneration	0.000251	0.000318	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—VEGFA—age related macular degeneration	0.000246	0.000312	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CETP—age related macular degeneration	0.000242	0.000307	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—APOE—age related macular degeneration	0.000241	0.000306	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—CD36—age related macular degeneration	0.000238	0.000303	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SLC16A8—age related macular degeneration	0.000233	0.000295	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—CD36—age related macular degeneration	0.000232	0.000295	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000223	0.000283	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000223	0.000283	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—C3—age related macular degeneration	0.000212	0.000269	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—APOE—age related macular degeneration	0.00021	0.000267	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—APOE—age related macular degeneration	0.000205	0.00026	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—LIPC—age related macular degeneration	0.000202	0.000257	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000199	0.000253	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—LIPC—age related macular degeneration	0.000198	0.000251	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—APOE—age related macular degeneration	0.000197	0.000251	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000197	0.00025	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CETP—age related macular degeneration	0.000195	0.000248	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KDR—age related macular degeneration	0.000193	0.000246	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CETP—age related macular degeneration	0.000191	0.000242	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CD36—age related macular degeneration	0.000188	0.000239	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000181	0.00023	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.000179	0.000228	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000175	0.000223	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—LIPC—age related macular degeneration	0.000171	0.000217	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—APOE—age related macular degeneration	0.000166	0.000211	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCL2—age related macular degeneration	0.000166	0.000211	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CETP—age related macular degeneration	0.000165	0.00021	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00016	0.000203	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000155	0.000197	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CD36—age related macular degeneration	0.000154	0.000195	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—LIPC—age related macular degeneration	0.000153	0.000194	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CETP—age related macular degeneration	0.000147	0.000187	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CD36—age related macular degeneration	0.000145	0.000185	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—LIPC—age related macular degeneration	0.000139	0.000177	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000137	0.000174	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—APOE—age related macular degeneration	0.000136	0.000172	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CETP—age related macular degeneration	0.000134	0.000171	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—APOE—age related macular degeneration	0.000128	0.000163	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—LIPC—age related macular degeneration	0.000119	0.000151	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CD36—age related macular degeneration	0.000117	0.000149	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CETP—age related macular degeneration	0.000115	0.000146	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CD36—age related macular degeneration	0.000115	0.000146	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—VEGFA—age related macular degeneration	0.000107	0.000135	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—APOE—age related macular degeneration	0.000103	0.000131	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—APOE—age related macular degeneration	0.000101	0.000128	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CD36—age related macular degeneration	9.93e-05	0.000126	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—LIPC—age related macular degeneration	9.19e-05	0.000117	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CETP—age related macular degeneration	8.86e-05	0.000113	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CD36—age related macular degeneration	8.86e-05	0.000113	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—APOE—age related macular degeneration	8.76e-05	0.000111	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CD36—age related macular degeneration	8.08e-05	0.000103	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—APOE—age related macular degeneration	7.82e-05	9.93e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—APOE—age related macular degeneration	7.13e-05	9.05e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CD36—age related macular degeneration	6.9e-05	8.77e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—APOE—age related macular degeneration	6.09e-05	7.73e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CD36—age related macular degeneration	5.33e-05	6.77e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—APOE—age related macular degeneration	4.7e-05	5.97e-05	CbGpPWpGaD
